Changes in cytoskeletal organization in polyoma middle T antigen-transformed fibroblasts: involvement of protein phosphatase 2A and src tyrosine kinases

Cell Motil Cytoskeleton. 2000 Dec;47(4):253-68. doi: 10.1002/1097-0169(200012)47:4<253::AID-CM1>3.0.CO;2-S.

Abstract

The major transforming activity of polyomavirus, middle T antigen, targets several cellular regulatory effectors including protein phosphatase 2A and src tyrosine kinases. Although transformed cells exhibit profound morphological changes, little is known about how middle T antigen-induced changes in the cellular regulatory environment specifically affect the cytoskeleton. We have investigated these changes in 10T(1/2) mouse fibroblasts transformed with polyoma middle T antigen. Immunofluorescence microscopy revealed that expression of middle T antigen (Pym T cells) depleted the stable (acetylated) microtubule array and increased the sensitivity of dynamic (tyrosinated) microtubules to nocodazole-induced disassembly. These effects were associated with a modest but statistically significant (P</=0.05) increase in recovery of protein phosphatase 2A activity with microtubules. Middle T antigen expression also depleted the normal cellular complement of actin stress fibers and focal adhesions, in parallel with changes in the distribution of src tyrosine kinases. Herbimycin A promoted recovery of paxillin and phosphotyrosine into nascent focal adhesion sites, in addition to restoring normal src tyrosine kinase distribution. However, herbimycin A did not restore actin stress fibers or parental-type microtubules to Pym T cells. We suggest that regulation of the microtubule array by middle T antigen may occur through direct effects including redistribution of protein phosphatase 2A as well as indirect effects such as altered interactions with actin-based stress fibers.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / metabolism
  • Animals
  • Antigens, Polyomavirus Transforming / metabolism*
  • Antineoplastic Agents / pharmacology
  • Benzoquinones
  • Cell Line
  • Cell Line, Transformed
  • Cytoskeletal Proteins / metabolism
  • Cytoskeleton / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Fibroblasts / metabolism*
  • Focal Adhesions / metabolism
  • Lactams, Macrocyclic
  • Mice
  • Microscopy, Fluorescence
  • Microtubules / metabolism
  • Nocodazole / pharmacology
  • Paxillin
  • Phosphoprotein Phosphatases / metabolism*
  • Phosphoproteins / metabolism
  • Phosphotyrosine / metabolism
  • Protein Phosphatase 2
  • Quinones / pharmacology
  • Rifabutin / analogs & derivatives
  • Stress Fibers / metabolism
  • Tyrosine / metabolism
  • Vimentin / metabolism
  • src-Family Kinases / metabolism*

Substances

  • Actins
  • Antigens, Polyomavirus Transforming
  • Antineoplastic Agents
  • Benzoquinones
  • Cytoskeletal Proteins
  • Enzyme Inhibitors
  • Lactams, Macrocyclic
  • Paxillin
  • Phosphoproteins
  • Pxn protein, mouse
  • Quinones
  • Vimentin
  • Rifabutin
  • Phosphotyrosine
  • Tyrosine
  • herbimycin
  • src-Family Kinases
  • Phosphoprotein Phosphatases
  • Protein Phosphatase 2
  • Nocodazole